The hearing is the first public trial to emerge from roughly 2,000 U.S. lawsuits aimed at holding drug companies accountable for their alleged role in the nation’s raging opioid crisis. “I expect a very spirited trial,” said local attorney and author Bob Burke. In other news on the epidemic: JPMorgan cuts ties with Purdue Pharma, the American Pain Society is considering filing for bankruptcy, and buprenorphine gains popularity as an addiction treatment.
from Kaiser Health News http://bit.ly/2X1Lgmw
May 24, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Doctor que fue trabajador agrícola crea santuarios de atención médica… Read More
Facebook Live: Inclusive Care at the End of Life: The LGBTQ+ Experience //![CDATA[ ( function() { var func = function() { var iframe = document.getElementById('wpcom-iframe-8ecaa5eaecb62790b9e82c7b8bc6e8de') … Read More
Did The ACA Create Preexisting Condition Protections For People In Employer Plans?… Read More
In Big Win For Merck, Supreme Court Tosses Ruling That Would Have Revived Hundreds Of Lawsuits Against DrugmakerThe justices want a federal appeals court to reconsider its 2018 ruling that allowed the lawsuits to proceed. The ruling centers around accusations that Merck didn't properly warn patients about thigh-bone fractures linked to… Read More
Viewpoints: We Need More Diversity In Health Workforce To Undercut Institutional Racism; Fat Gene Test Could Scare People Into Unhealthy ChoicesEditorial writers and columnists focus on these and other health issues such as superbugs, Medicare, gun safety and more. from Kaiser Health News http://bit.ly/2VVifwj … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment